The Mysterious Hormone Called Klotho
Dr. Dena Dubal worked to understand how to enhance the brain's capabilities. Now she is trying to build treatments based on these results.
We Give A Big Welcome to Anthony Francis
Innovation Ventures is proud to announce the addition of Anthony Francis, Executive Director of our Office of Technology Management group.
Sana Biotechnology Launches Focusing on New Class of Medicine
UCSF's Sonja Schrepfer helps found startup Sana Biotechnology, as they launch with a focus on engineering cells to create a new class of medicines.
CRISPR-mediated Activation to Reduce Obesity
Catalyst Awardees, Nadav Ahituv, PhD and Navneet Matharu, PhD, Apply CRISPR-mediated Activation to Obesity. Here are the results:
Mission Bio Raises $30M To Expand Tapestri’s Reach
Mission Bio raise $30M in series B funding with Adam Abate’s work on single-cell DNA analysis platform Tapestri®.
Principia Revealed In Generous IPO
SUCCESS STORIES
Principia Biopharma founded by Jack Taunton, began trading at $17.00 per share on the Nasdaq, raising approximately $122.2 million for immunology and cancer treatment.
FDA Clears FOR46 For Clinical Trials
SUCCESS STORIES
Fortis Therapeutics receives FDA clearance for two INDs to treat late-stage prostate cancer and multiple myeloma.
Radio Frequency Sedative Gets FDA Nod
SUCCESS STORIES
FDA grants 510(K) clearance to Relievant Medsystems leading to Its first commercial intracept procedures and $58 Million in equity funding.
Health Hub Launches in Collaboration with UCSF
Next-generation nonprofit Health Hub and UC San Francisco have announced plans to bring inventors and local entrepreneurs the support and professional development needed to build successful companies.
Venn Acquires Cancer Immunotherapy Antibody
Venn Therapeutics has completed an exclusive licensing deal with the University of California, San Francisco (UCSF) to advance its novel integrin αvβ8 antibody, created by a team of preeminent scientists at UCSF, led by Dr. Stephen Nishimura.

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...